[
    [
        {
            "time": "2021-07-18",
            "original_text": "康泰生物：全资子公司与嘉晨西海签署战略合作协议",
            "features": {
                "keywords": [
                    "康泰生物",
                    "全资子公司",
                    "嘉晨西海",
                    "战略合作协议"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：全资子公司与嘉晨西海签署战略合作协议",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "康泰生物子公司与嘉晨西海合作 联合布局mRNA人用传染病疫苗",
            "features": {
                "keywords": [
                    "康泰生物",
                    "子公司",
                    "嘉晨西海",
                    "mRNA",
                    "人用传染病疫苗"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物子公司与嘉晨西海合作 联合布局mRNA人用传染病疫苗",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "康泰生物(300601.SZ)可转债网上中签结果出炉：中签号共130.1816万个",
            "features": {
                "keywords": [
                    "康泰生物",
                    "可转债",
                    "中签结果",
                    "130.1816万个"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)可转债网上中签结果出炉：中签号共130.1816万个",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "康泰生物：可转债中签号出炉超130万个",
            "features": {
                "keywords": [
                    "康泰生物",
                    "可转债",
                    "中签号",
                    "130万个"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：可转债中签号出炉超130万个",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "康泰生物(300601.SZ)与嘉晨西海签署mRNA人用传染病疫苗项目战略合作协议",
            "features": {
                "keywords": [
                    "康泰生物",
                    "嘉晨西海",
                    "mRNA",
                    "人用传染病疫苗",
                    "战略合作协议"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)与嘉晨西海签署mRNA人用传染病疫苗项目战略合作协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "康泰生物：子公司签署mRNA人用传染病疫苗项目战略合作协议",
            "features": {
                "keywords": [
                    "康泰生物",
                    "子公司",
                    "mRNA",
                    "人用传染病疫苗",
                    "战略合作协议"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：子公司签署mRNA人用传染病疫苗项目战略合作协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "医药行业周报：中报预告落地 个股表现持续分化",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "中报预告",
                    "个股分化"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业周报：中报预告落地 个股表现持续分化",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-18",
            "original_text": "下周操盘策略：定价成长，寻找下一只创业板翻倍股",
            "features": {
                "keywords": [
                    "操盘策略",
                    "定价成长",
                    "创业板",
                    "翻倍股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "下周操盘策略：定价成长，寻找下一只创业板翻倍股",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]